A groundbreaking analysis published in The Lancet Psychiatry has identified escitalopram as the most effective antidepressant in preventing relapses among patients suffering from depression. Conducted over a year, the study involved nearly 10,000 individuals prescribed various medications and found that escitalopram outperformed Prozac (fluoxetine) in keeping patients symptom-free. Agomelatine and duloxetine followed closely behind. Experts caution, however, that the findings do not imply a universal switch to escitalopram or a dismissal of other antidepressants' efficacy due to their unique advantages and disadvantages. Depression, affecting approximately one in six people in the UK, can be effectively treated with appropriate care and support, but recurrence remains possible. To minimize relapse, doctors often recommend extending antidepressant use for at least six months post-depression cessation before gradually tapering off.
The analysis compared the effectiveness of over a dozen common antidepressants. The differences found were modest, with longer studies needed to further understand these medications' impact on depression. Depression's causes are multifaceted, and treatment options encompass both drugs and talking therapies. Patients should engage in informed discussions with their doctors about the best treatment choices. Medical guidelines typically recommend SSRI antidepressants like escitalopram, sertraline, fluoxetine (Prozac), or others as first-line treatments due to their serotonin-boosting properties.
The choice of medication can vary per individual, according to one of the researchers, Prof Eric Ruhé from Radboud University in The Netherlands. He emphasized that these findings could aid prescribers and patients in making informed decisions about their antidepressant choices: "Choose one that not only helps you get well but also keeps you well." However, Dr Sameer Jauhar from Imperial College London cautioned that the research could not pinpoint which antidepressant would work best for an individual patient. He urged against using these findings as a reason to alter treatment for those currently responding positively to their medication.
Like all medications, escitalopram can cause side effects such as sleep problems, constipation, and weight gain. If ineffective or unsuitable, doctors may suggest alternative antidepressants like SNRIs. Older tricyclic antidepressants, such as amitriptyline, are now less frequently prescribed. The mental health charity Mind underscores the need for people to have access to clear information about antidepressant benefits, side effects, and other support options like talking therapies and mindfulness. People may need to try multiple medications before finding the one that works best for them, with effectiveness potentially changing over time. Mind's website offers comparative information on various antidepressants.